State of Decay resubmitted to Australian Classification Board
Zombie-survival game resubmitted for classification in Australia.
A modified version of State of Decay has been submitted to the Australian Classification Board, developer Undead Labs has announced on its official Facebook page.
Zombie-survival game State of Decay was revealed as being effectively banned from sale in Australia last week for containing "illicit or proscribed drug use related to incentives or rewards".
A special edition of the game has been submitted for classification, with the developer saying in the Facebook post, "Stimulants out! 'Supplements' in!"
Prior to resubmission, State of Decay's in-game medications consisted of both illicit and legal substances, which included methadone, morphine, amphetamines, stimulants, acetaminophen, ibuprofen, codeine, aspirin, "trucker pills", painkillers, and tussin.
Undead Labs also made reference to a PC release, saying the game will be on Steam, but "not soon".
State of Decay focuses on surviving in a zombie-infested world, and promises a dynamically generated experience that changes in real time.
Since its North American release, the game has sold over 500,000 copies on Xbox Live Arcade within three weeks, making it the fastest-selling original game on XBLA.
Fallout 4 Next Gen Update Comparison Stellar Blade - Hard Mode No Damage Gigas Boss Gameplay Stellar Blade - Hard Mode No Damage Abaddon Boss Gameplay Stellar Blade - (Almost) All Outfits Granblue Fantasy: Relink - New Content Trailer Modern Warfare III - New Season 3 Reloaded Modern Warfare Zombies Update River City Girls 2 - New Playable Characters DLC Reveal!! That Time I Got Reincarnated as a Slime ISEKAI Chronicles – Official Announcement Trailer MEGATON MUSASHI W: WIRED – Official OP “MUSASHI English Ver.” Trailer Gothic 1 Remake | Official Collector's Edition Trailer SaGa Emerald Beyond – Official Launch Trailer Paper Mario: The Thousand-Year Door – Official Switch Overview Trailer
Please enter your date of birth to view this video
By clicking 'enter', you agree to GameSpot's
Terms of Use and Privacy Policy
Got a news tip or want to contact us directly? Email news@gamespot.com
Join the conversation